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Abstract
The following essay was written by a freshman undergraduate student majoring in Bioengineering
at the University of Maryland, Mr. Zachary Russ. Mr. Russ was one of 94 students who submitted
a 1000 to 1200 word essay to the 3rd Annual Bioethics Essay Contest sponsored by the Institute
of Biological Engineering (IBE). A group of professionals in Biological Engineering assessed and
ranked the essays in a blinded process. Five semi-finalists were invited to present their essays at a
session at the annual meeting of IBE in Chapel Hill, NC on March 8, 2008. Five judges scored the
presentations at the annual meeting and selected Mr. Russ's contribution as the overall winner (1st
Place). Below is his essay.
Introduction
Nobel Laureate and physicist Richard P. Feynman once
wrote, "What I cannot create, I do not understand." In the
field of biology, this quote is very apropos. Bioengineer-
ing, for all of its accomplishments, still has yet to create
life to fit the same sort of precise specifications that chem-
ical engineers have done with molecules and that
mechanical engineers have with machines. Life is too
unpredictable and poorly understood to reach its full
engineering potential. The newly introduced field of syn-
thetic biology (synbio) represents a response to that prob-
lem. Synbio is epitomized by the BioBricks project, which
attempts to create life from scratch with clearly defined
and understood interactions between each engineered
gene. One success of the BioBricks approach is the com-
plete rewrite of the T7 bacteriophage, which behaves
much like the original, but in a very predictable fashion
[1]. Synbio, much like genetic engineering in general, is
not without its critics.
Many of the public's fears are reflected in The Guardian
columnist Madeleine Bunting's assertion that "[s]cientists
have a new way to reshape nature, but none can predict
the cost [2]." Bunting writes that synbio "is a frightening
science," that it "has the potential to be highly accessible
... making the task of regulating its use extremely diffi-
cult," and synthetic organisms can "get out and cross with
their wild cousins, mutating into organisms we had never
foreseen." She expresses concern over the "massive and
momentous consequences," comparing synbio to the
Industrial Revolution. Professional scientists' concerns are
more limited to feasibility, suggesting that it is unlikely
humans can design a better biological machine than
nature can.
Many of these concerns stem from a misunderstanding of
synbio. Synbio is a new approach to genetic engineering
that knocks out of the genome the byproducts of evolu-
tion either by designing the organism from scratch or
removing all of the nonessential DNA from an existing
organism. The BioBricks project takes the former
approach, and, by designing organisms using standard-
ized building blocks, makes genetic engineering easier
and much more efficient. BioBricks provide the potential
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to make biochemicals and pharmaceuticals quickly and
easily without having to worry about unforeseen interac-
tions between the drug genes and vestigial genes [3]. Life
effectively becomes predictable and can be modeled by
equations. All nonessential processes can be removed in
synthetic organisms, so more energy and resources go
towards making the product. In the process, engineers
gain a greater understanding of life and its mechanisms.
But what of the drawbacks? What will happen if a syn-
thetic organism escapes a lab? Most likely, nothing. With
complete control over the genomes of their organisms,
synbioengineers can introduce specific weaknesses into
their organisms, such as a dependency on a particular
amino acid, so that lab experiments have little chance of
surviving in the wild. Without the noise data that natural
organisms have in their genomes, synthetic organisms
will also be very limited in genetic variation and virtually
unable to adapt to new conditions. The probability of
them hybridizing with wild varieties is also limited – they
are synthetic organisms that have little in common with
natural life and thus even less chance of recombinants sur-
viving. Compared to organisms created using previous
genetic engineering methods, synthetic organisms are
much safer, not only because they lack the survival tech-
niques found in nature, but also because they are better
understood. Every gene in the organism is there intention-
ally with a specific purpose and a known function. This
greatly lessens the risk of unknown genes triggering aller-
gic reactions, one of the major fears in genetically modi-
fied food.
While accidental harm is significant, in the age of terror-
ism in which we live, malice is also an important factor in
technologies. While the accessibility of BioBricks makes
regulation difficult, synthetic biology is (and will proba-
bly continue to be) a long way from a basement technol-
ogy. Those who would wish to visit destruction on the
human race have much easier, more convenient tools
available. Nature has already provided massive numbers
of harmful organisms, and deadly chemicals are easier to
manage and create. With so many variables, the human
body is a far cry from the controlled laboratory environ-
ment that synthetic biology addresses. Scientists would
have enormous difficulty in creating a virulent pathogen
instead of a simple microbe designed to produce a chem-
ical in a sterile, stable environment. Even the advent of
computer programming provided an easy route to
destruction, much easier than the slight advantage Bio-
Bricks provides, by allowing individual computer crackers
to cause billions of dollars of damage with a few days of
work, but few would argue against the information revo-
lution for this threat.
There is even more risk to not using synthetic biology.
Synthetic biology can produce organisms to clean up pol-
lution and provide clean energy. Proteins and food can be
created without wasting energy on a full-sized organism,
providing cheap ways to make nutritious meals for mil-
lions. Without the help of synthetic biology, the Earth
may just become uninhabitable for humans as pollutants
build up and as the climate changes. The dangers posed to
the human race are not from genetic engineering so much
as they are from well-understood technologies and mech-
anisms – wasteful energy use, inefficient land use, and
straightforward destruction. In many developing coun-
tries, respiratory problems stemming from pollution are a
persistent and growing problem. Synthetic organisms
hold the potential to manufacture products with minimal
waste cleanly and efficiently, and some may even alleviate
the threat of a poisonous atmosphere by breaking down
specific toxins.
Ultimately, synthetic biology is about complete under-
standing. Synbio is the opportunity to gain power over life
and achieve the ultimate goal in engineering – to be so
familiar with a part that its behavior can be modeled, pre-
dicted, and used; and the uses are limitless. Already, a syn-
bio project is close to producing large quantities of
artemisinin, an antimalarial chemical [4]; other projects
are aimed to make biosensors, anticancer microbes, and
clean petrochemicals. Synbio is the next step in the
growth of genetic engineering, and it offers a great hope
for not only helping humanity but also minimizing the
potential pitfalls of genetic engineering. Synthetic biology
should be embraced, not feared, for the immense poten-
tial it has. As the MIT AI Lab's Tom Knight said, "the
genetic code is 3.6 billion years old. It's time for a rewrite
[5]."
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